** Shares in Siemens Healthineers SHLG.DE drop around 5% in early Frankfurt trade after the German medical technology company reported fourth-quarter revenues that slightly missed expectations and gave a 2026 outlook
** Q4 revenue was 6.32 billion euros ($7.37 billion), compared to the 6.45 billion expected by analysts polled by Vara Research
** The company said it expects comparable revenue growth of between 5% to 6% for 2026 compared with 2025 and adjusted basic EPS to be between 2.20 euros and 2.40 euros
** "Very weak EPS outlook for FY25/26 will hurt shares, even though company normally guides conservatively," a local trader says
** Still, Jefferies analysts say "cautious" 2026 guidance leaves room for upside and that Siemens Healthineers had flagged headwinds for the year including tariffs
** "FY26 likely a transition year and a basis for SHL's new multi year plan to be unveiled at its upcoming CMD (17 Nov)," they add
(Reporting by Marleen Kaesebier)
((marleen.kaesebier@thomsonreuters.com))